Amer Alomar

Dr. Amer Alomar

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
Ranjit SahRanjit Sah
Ranjit Sah
AAAbdelaziz Abdelaal
Abdelaziz Abdelaal
ARAbdullah Reda
Abdullah Reda
BKBasant E. Katamesh
Basant E. Katamesh
EMEmery Manirambona
Emery Manirambona
Alfonso J. Rodriguez-MoralesAlfonso J. Rodriguez-Morales
Alfonso J. Rodriguez-Morales
Monkeypox is a rare disease but is increasing in incidence in different countries since the first case was diagnosed in the UK by the United Kingdom (UK) Health Security Agency on 6 May 2022. As of 9 August, almost 32,000 cases have been identified in 89 countries. In endemic areas, the monkeypox virus (MPXV) is commonly transmitted through zoonosis, while in non-endemic regions, it is spread through human-to-human transmission. Symptoms can include flu-like symptoms, rash, or sores on the hands, feet, genitalia, or anus. In addition, people who did not take the smallpox vaccine were more likely to be infected than others. The exact pathogenesis and mechanisms are still unclear; however, most identified cases are reported in men who have sex with other men (MSM). According to the CDC, transmission can happen with any sexual or non-sexual contact with the infected person. However, a recent pooled meta-analysis reported that sexual contact is involved in more than 91% of cases. Moreover, it is the first time that semen analysis for many patients has shown positive monkeypox virus DNA. Therefore, in this review, we will describe transmission methods for MPXV while focusing mainly on potential sexual transmission and associated sexually transmitted infections. We will also highlight the preventive measures that can limit the spread of the diseases in this regard.

1 April 2015 in Journal of Medical Microbiology
Verified
Journal Article
Closed access
PDF file
RAReem Aljindan
Reem Aljindan
HBHuda Bukharie
Huda Bukharie
AAAmer Alomar
Amer Alomar
BABaha Abdalhamid
Baha Abdalhamid
Carbapenem resistant Acinetobacter baumannii are a major health problem especially in intensive care units (ICU) worldwide. This study aims to detect the prevalence of Acinetobacter baumannii colonization of the gastrointestinal tract of patients admitted to the intensive care units in two hospitals in Saudi Arabia. In addition, it aims to characterize the molecular mechanisms of carbapenem resistance in such isolates. From January to June 2014, 565 rectal swab specimens were screened for Acinetobacer strains and carbapenem resistance using chromagar Acinetobacter and chromagar KPC agar plates, respectively. Organism identification and susceptibility were detected using vitek2 system. A total of 47 Acinetobacter spp were detected and 35 of them were resistant to carbapenem making the prevalence of Acinetobacter spp 8.3% (47/565) and carbapenem resistance (6.2%, 35/565). The 47 strains had remarkable clonal diversity as revealed by pulse field gel electrophoresis. Using PCR, OXA-51, a chromosomal marker for Acinetobacter baumannii, was detected in 46 strains. OXA-23 beta lactamase was detected in all 35 carbapenem resistant Acinetobacter baumannii. No IMP-, VIM-, SPM-, SIM-, GIM, KPC-, and NDM-beta lactamases were detected in these isolates. OXA-23 is the main mechanism of carbapenem resistance in these isolates. To our knowledge, this is the first study to detect the prevalence of Acinetobacter colonization in the digestive tract of ICU patients in Saudi Arabia. This study reveals the importance of having well established protocols for early identification of these multi drug resistant organisms, optimizing infection control strategies, and having active surveillance studies to reduce morbidity, mortality, and cost.

28 January 2019 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
FAFaisal M. Alzahrani
Faisal M. Alzahrani
AMArray Muzaheed
Array Muzaheed
SSSaeed Sattar Shaikh
Saeed Sattar Shaikh
AAAmer Alomar
Amer Alomar
SASadananda Acharya
Sadananda Acharya
MUMuzaheed
Muzaheed
Alzahrani FM, et al. Ann Lab Med. 2019 Jan;39(1):81-85. https://doi.org/10.3343/alm.2019.39.1.81

21 July 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
Ranjit SahRanjit Sah
Ranjit Sah
AAAbdelaziz Abdelaal
Abdelaziz Abdelaal
ARAbdullah Reda
Abdullah Reda
BKBasant E. Katamesh
Basant E. Katamesh
EMEmery Manirambona
Emery Manirambona
Alfonso J. Rodriguez-MoralesAlfonso J. Rodriguez-Morales
Alfonso J. Rodriguez-Morales
Monkeypox is a rare disease which is rising nowadays in different countries since the first case in the UK was diagnosed on May 6, 2022, by the United Kingdom (UK) Health Security Agency. Then more than 12,500 cases were identified in over 68 countries up to July 18, 2022. In endemic areas, the monkeypox virus (MPXV) is commonly transmitted through zoonosis, while in non-endemic regions, it is spread through human-to-human transmission. Symptoms can include flu-like symptoms, rash, or sores in hands, feet, genitalia, or anus. In addition, people who did not take the smallpox vaccine were more liable to be affected than others. The exact pathogenesis and mechanisms are still unclear; however, most identified cases are reported in men who have sex with other men (MSM). According to the CDC, transmission can happen with any sexual or non-sexual contact with the infected person. However, a recent pooled meta-analysis reported that sexual contact is involved in more than 91% of the cases. Also, it is the first time that semen analysis for many patients has shown positive monkeypox virus DNA. Therefore, in this review, we will describe transmission methods for MPXV while focusing mainly on potential sexual transmission and associated sexually transmitted infections. We will also highlight the preventive measures that can limit the spread of the diseases in this regard.

1 April 2020 in Heliyon
Verified
Journal Article
Open access
NENasreldin Elhadi
Nasreldin Elhadi
RAReem Aljindan
Reem Aljindan
KAKhaldoon Alsamman
Khaldoon Alsamman
AAAmer Alomar
Amer Alomar
NENasreldin Elhadi
Nasreldin Elhadi
To investigate presence of Enteroaggregative Escherichia coli (EAEC) in patients suffering with diarrhea by targeting the pCVD432 (pAA) gene using PCR. There were 63 non-duplicate isolates of E. coli isolated from diarrheal cases in teaching hospital in Eastern Province of Saudi Arabia between May 2013 to July 2014. All E. coli strains were examined for antibiotic susceptibility testing and polymerase chain reaction (PCR) for detection of virulence gene markers for EAEC. Of the 63 E coli strains that were reported with diarrheal cases, 35 (55.6%) EAEC were tested positive for pCVD432 gene and aggR gene was present in 19 (54.3%) strains. All strains tested positive for pCVD432 and aggR genes were classified as typical EAEC (tEAEC). EAEC revealed resistance to tetracycline, ampicillin, nalidixic acid, trimethoprim sulfamethoxazole, ciprofloxacin, streptomycin, noroxin, and piperacillin. EAEC was detected for the first time, among Saudi patients with diarrhea in this region of Saudi Arabia. The reported antibiotic resistance in this study is considered high among isolated EAEC strains to routinely prescribed antibiotics in our area.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FAFaisal M. Alzahrani
Faisal M. Alzahrani
AAAli Al-Amri
Ali Al-Amri
SSSaeed Sattar Shaikh
Saeed Sattar Shaikh
M.Muzaheed ..
Muzaheed ..
AAAmer Alomar
Amer Alomar
FHFath-alrahman Hassan
Fath-alrahman Hassan
Introduction. Bloodstream infections (BSI) among patients with hematological malignancies (HM) could predispose them to higher morbidity and mortality for various underlying conditions. Several microorganisms, either pathogenic or opportunistic normal human flora, could cause severe bacteremia and septicemia. While conventional methods have their own limitations, molecular methods such as next‐generation sequencing (NGS) can detect these blood infections with more reliability, specificity, and sensitivity, in addition to information on microbial population landscape. Methodology. Blood samples from HM patients (n = 50) and volunteer blood donor control individuals with no HM (n = 50) were subjected to 16S rRNA gene amplification using standard PCR protocols. A metagenomic library was prepared, and NGS was run on a MiSeq (Illumina) sequencer. Sequence reads were analyzed using MiSeq Reporter, and microbial taxa were aligned using the Green Genes library. Results. 82% of the patients showed BSI with Gram‐negative bacteria as the most predominant group. E. coli comprised a major chunk of the bacterial population (19.51%), followed by K. pneumoniae (17.07%). The CoNS and Viridans Streptococci groups are 17.07% and 14.63%, respectively. Other major species were S. aureus (9.75%), P. aeruginosa (7.31%), A. baumannii (4.87%), E. cloacae (4.87%), and P. mirabilis (4.87%). 34.14% of the cases among patients showed a Gram‐positive infection, while 14.63% showed polymicrobial infections. Conclusion. Most of the BSI in patients were characterized by polymicrobial infections, unlike the control samples. Molecular methods like NGS showed robust, fast, and specific identification of infectious agents in BSI in HM, indicating the possibility of its application in routine follow‐up of such patients for infections.